Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Awareness Among the Consumers
4.2.2 Increasing Prevalence of Chronic Diseases
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.3.2 Stringent Regulatory Policies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Test Type
5.1.1 Proteins
5.1.2 Kidney Tests
5.1.3 Electrolytes
5.1.4 Liver Function Tests
5.1.5 Glucose
5.1.6 Others
5.2 By Disease
5.2.1 Kidney Diseases
5.2.2 Diabetes
5.2.3 Liver Diseases
5.2.4 Others
5.3 By End-User
5.3.1 Point of Care Centers
5.3.2 Laboratories
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Quest Diagnostics
6.1.2 Laboratory Corporation of America Holdings
6.1.3 Sonic Healthcare Limited
6.1.4 Synlab Hrvatska
6.1.5 Charles River Laboratories, Inc.
6.1.6 ARUP Laboratories.
6.1.7 NeoGenomics Laboratories, Inc.
6.1.8 Genoptix, Inc.
6.1.9 CENTOGENE N.V.
6.1.10 UNIPATH


7 MARKET OPPORTUNITIES AND FUTURE TRENDS